What Happens If You Miss a Dose of Growth Hormone?

Missing a single dose of growth hormone is not a medical emergency and will not cause any immediate harm. Growth hormone therapy works cumulatively over months and years, so one skipped injection barely registers in the body’s response. The real concern is a pattern of missed doses: research consistently shows that children who miss more than about one injection per week grow measurably less than those who stick to their schedule. For adults on replacement therapy, chronic gaps affect body composition and cholesterol rather than height. Understanding where the line falls between “no big deal” and “clinically meaningful” is what most patients and caregivers actually need.

Why a Single Missed Dose Doesn’t Matter Much

Growth hormone injections are designed to mimic the body’s natural pulses of the hormone, which happen mainly during deep sleep. Your body doesn’t rely on a single pulse to function. One study comparing continuous overnight delivery versus a single daily injection found no differences in growth velocity or the circulating levels of IGF-1, the downstream marker of growth hormone activity.¹ If even the delivery pattern within a single day doesn’t change outcomes, it follows that skipping one day out of seven is unlikely to derail treatment.

Endocrinologists generally advise patients who miss a dose to simply skip it and take the next scheduled injection at the usual time. Doubling up is not recommended. The medication’s effects build gradually through consistent daily exposure, not through any one shot.

When Missed Doses Start to Hurt Growth

The picture changes when skipping becomes a habit. A study of 110 children on daily growth hormone tracked actual compliance by counting returned medication vials. The estimated rate of non-compliance, defined as missing more than one injection per week, was strikingly high at 66%. Children who missed more than one dose a week had significantly reduced linear growth compared to those who kept up with their schedule.² Growth velocity rose in a dose-response fashion as compliance improved, meaning each additional dose taken per week translated into more centimeters gained.

Interestingly, not every study finds a dramatic short-term difference. One analysis of 174 children with growth hormone deficiency compared height velocity between adherent and non-adherent groups and found the difference was not statistically significant, with the adherent group gaining about 10.2 cm per year versus 9.8 cm in the non-adherent group.³ That might sound reassuring, but the non-adherent group had wide variability in their results, and small annual differences compound over the years of treatment a child typically needs. A child who grows half a centimeter less per year for five years ends up two and a half centimeters shorter than they could have been.

The clinical consensus is clear even when individual studies show modest short-term effects: suboptimal adherence to daily growth hormone therapy is a real barrier to reaching a child’s full growth potential, and strategies to improve consistency are a priority in pediatric endocrinology.⁴

What Happens to Your Metabolism When Growth Hormone Stops

Growth hormone does more than drive height. It plays a role in fat metabolism, cholesterol regulation, and blood sugar handling. When researchers studied patients with childhood-onset growth hormone deficiency who stopped treatment during the transition to adulthood, the metabolic shifts were measurable within months. BMI Z-scores climbed, meaning patients gained body fat relative to their height. Total cholesterol rose from roughly 171 to 185 mg/dL, LDL cholesterol jumped from about 104 to 121 mg/dL, and non-HDL cholesterol also increased. Meanwhile, IGF-1 and IGFBP-3 levels, the main blood markers of growth hormone activity, dropped sharply.⁵

These changes matter most for adults who rely on growth hormone replacement long term. A child who misses a week of injections before a vacation is not going to see their cholesterol spike. But an adult who drifts away from treatment for months should expect unfavorable shifts in body fat distribution and lipid levels, effectively reversing some of the metabolic benefits the therapy provides. One curious finding from the same study: fasting blood glucose actually decreased slightly during the treatment gap, from about 92 to 87 mg/dL. Growth hormone has a mild glucose-raising effect, so stopping it can paradoxically improve fasting sugar in the short term. That does not mean stopping is a net benefit; the cholesterol and body-composition changes outweigh it.

How Common Is It to Miss Doses?

If you or your child have missed injections, you are in large company. Growth hormone therapy requires daily subcutaneous injections, often for years, and that is a tough ask for anyone. A large real-world study of U.S. pediatric patients found that roughly one in five had suboptimal adherence by the 12-month mark. By 48 months, that figure had climbed to over a third.⁶ Adherence tends to erode the longer treatment continues, which makes sense: the initial enthusiasm and novelty wear off, and the nightly injection becomes one more chore.

A meta-analysis pooling data across multiple studies found an overall mean adherence rate of about 92% of prescribed doses taken. Patients receiving newer long-acting growth hormone formulations, which require weekly rather than daily injections, had slightly better adherence at 94% versus 91% for daily users. A greater share of the long-acting group hit the 90% adherence threshold as well.⁷ The difference sounds small in percentage terms, but when mapped across years of treatment, even a few extra missed doses each month can add up.

Why People Miss Doses

The reasons behind non-adherence are not mysterious, but they are stubbornly persistent. A review of factors influencing compliance identified several recurring themes: misperceptions about what happens when a dose is missed, discomfort with injections, dissatisfaction with how quickly results appear, and not enough contact with the prescribing physician.⁸ That first factor, misperceptions about missed doses, is worth emphasizing. Some families believe that missing a dose will cause immediate harm and feel so guilty or anxious about a lapse that they become demoralized and skip more. Others assume one missed dose means nothing and let occasional skips become habitual. Both extremes are counterproductive.

Parents themselves have described a psychological catch-22 specific to growth hormone therapy: skipping an injection is not followed by any immediate negative consequence, and the positive effects of consistent treatment are hard to link directly to the shots because results unfold over months. That disconnect makes it easy to rationalize skipping “just tonight.”⁹ Unlike missing a dose of, say, an asthma inhaler where you feel wheezy the same day, a missed growth hormone injection has no perceptible feedback loop. The consequences are invisible until you measure height velocity months later.

For children with chronic kidney disease, additional barriers pile on. A study of this population found that missed appointments and being lost to follow-up were the most common obstacles, followed by severe developmental delay that made administering injections harder, and medical complications that interrupted treatment.¹⁰ Families dealing with complex medical conditions have so many competing demands that growth hormone can slide down the priority list.

The Cost of Poor Adherence Goes Beyond Height

Growth hormone is one of the more expensive medications a family can encounter. Poor adherence creates a frustrating economic paradox: the medication is still being purchased and partially used, but the clinical benefit is diminished. A clinical review found that non-adherence leads to both reduced treatment outcomes and increased overall healthcare costs, because inadequately treated patients may require longer treatment courses, additional diagnostic workups, or dose adjustments that would have been unnecessary with consistent use.¹¹ In practical terms, if you are paying for the medication but only using it five nights out of seven, you are getting less than five-sevenths of the benefit because the body’s response to growth hormone depends on sustained, consistent exposure.

Does It Matter What Time of Day You Inject?

Most endocrinologists recommend evening injections because the body naturally releases the bulk of its growth hormone during early sleep. This has led to a common worry: if you take the shot in the morning instead, or at an irregular time, are you undermining its effectiveness? A study comparing morning versus evening injection schedules in children found no meaningful differences in sleep quality, total sleep time, sleep efficiency, or daytime alertness between the two timing strategies. All measured sleep parameters fell within normal pediatric ranges regardless of when the injection was given.¹²

The practical takeaway is that consistency matters more than clock precision. If a family finds mornings easier to remember and evenings chaotic, switching to a morning schedule is preferable to missing doses because the evening routine keeps falling apart. Discuss any timing change with your endocrinologist, but the evidence suggests the body is fairly flexible about when it receives its growth hormone.

Electronic Devices and Apps That Track Injections

One of the newer tools in the adherence toolkit is connected injection devices that automatically log when a dose is given. These devices record the date, time, and dose of each injection and can transmit the data to a smartphone app or directly to the clinical team. An observational study using one such electronic device in Taiwan confirmed that patients with inadequate adherence and poor treatment response could be identified through the device’s data, allowing earlier clinical intervention.¹³

A Japanese study using a smartphone app linked to an electronic injection device took this a step further, finding that higher engagement with the app (measured by how actively kids used in-app features like avatar rewards) correlated with more injections administered. The association was strongest in children under 12; teenagers showed no significant link between app engagement and adherence.¹⁴ Gamification works for younger kids but loses its pull as children age into adolescence, which is unfortunately when adherence tends to slip the most.

Beyond simple reminders, these injection logs can reveal subtle patterns. One analysis found that reviewing electronic logs could detect irregular injection schedules caused by disrupted daily routines, such as a “night owl” sleep pattern that pushed bedtime injections into the early morning hours or caused them to be forgotten entirely.¹⁵ Sharing this data with the care team opens up conversations about practical fixes, like adjusting injection timing to better match a family’s actual schedule.

Weekly Injections and Whether They Help

The most significant development in growth hormone adherence may be the arrival of long-acting formulations that require only one injection per week instead of seven. These formulations maintain more stable growth hormone levels across the week, removing the daily burden that drives so much non-compliance. As noted earlier, meta-analytic data show that patients on long-acting growth hormone achieve adherence rates of about 94% versus 91% for daily regimens, and a substantially higher proportion reach the 90% threshold.⁷

What happens if you miss a weekly dose? The stakes per missed injection are higher in one sense: you are losing a full week’s worth of hormone exposure rather than one day’s worth. But the flip side is that patients on weekly regimens miss far fewer doses overall, so the net effect on treatment tends to be favorable. If you do miss a weekly injection, most prescribing guidelines suggest taking it as soon as you remember, provided the next scheduled dose is still at least a few days away. If you are close to your next dose, skip the missed one entirely rather than doubling up.

Letting Children Choose Their Device

Growth hormone can be delivered through several types of pen injectors, and some clinics allow children and families to choose which device they prefer. The logic is that a child who feels ownership over their treatment tool will be more motivated to use it. The evidence on this is mixed. One study found adherence of about 93% in a group that chose their own device compared to 67% in a group that did not get a choice. However, another study found that offering a choice made no significant difference, though adherence remained above 85% in both groups.¹⁶ The conflicting results suggest that device choice might help some families more than others, and it is probably not the sole answer to adherence problems. Still, when a child actively resists their current injector, trying a different one is a low-risk move.

The Teenager Problem

Adolescence is where growth hormone adherence typically hits its lowest point. Teenagers increasingly manage their own injections, which coincides with a developmental stage where long-term health consequences feel abstract and daily routines are in flux. The U.S. real-world data showing adherence dropping from about 80% at one year to roughly 64% by four years captures this trajectory, as many of those patients age through puberty during that interval.⁶ The Japanese app study’s finding that gamification stops working in children over 12 fits the same pattern.¹⁴

This is also the period when growth hormone treatment matters most, because the pubertal growth spurt is the last major opportunity for height gain before the growth plates close. Missing doses during this window has a disproportionate impact on final adult height compared to missed doses at, say, age six, when years of treatment still lie ahead. Clinicians who work with teenagers on growth hormone often shift the conversation from parental reminders to helping the teen internalize the routine themselves, sometimes by connecting treatment goals to things the teenager cares about, like sports performance or keeping up with peers.

When Stopping Treatment Is Actually the Plan

Not all treatment gaps are accidental. Endocrinologists sometimes deliberately pause growth hormone therapy to reassess whether a patient still needs it. In children who were diagnosed with growth hormone deficiency early in life, retesting after puberty sometimes reveals that the deficiency has resolved. A planned discontinuation is managed differently from an accidental lapse: blood work is drawn before and after the break to track IGF-1 levels, cholesterol, and body composition. The metabolic changes seen in the transition study, rising LDL and body fat, occur even during planned pauses, but they are monitored and expected rather than accumulating unnoticed.⁵ If retesting confirms ongoing deficiency, treatment is restarted and the metabolic markers typically improve again.

For adults on lifelong growth hormone replacement, any extended break should ideally be coordinated with an endocrinologist rather than happening by default because refills lapsed or life got busy. The metabolic consequences are manageable and reversible, but only if someone is watching the numbers.